Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc.(TRDA) | 4,425,784 | 4,381,062 | -44,722 | $70.72M | $75.75M | 60.89% | +$5.02M |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | $27.96M | $21.03M | 16.91% | -$6.93M |
| Dyne Therapeutics, Inc.(DYN) | 682,376 | 682,376 | 0 | $24.51M | $16.08M | 12.92% | -$8.43M |
| Werewolf Therapeutics, Inc.(HOWL) | 4,284,172 | 4,284,172 | 0 | $9.08M | $6.34M | 5.10% | -$2.74M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,555,461 | 5,555,461 | 0 | $5.28M | $2.99M | 2.41% | -$2.28M |
| Repare Therapeutics, Inc. | 2,242,636 | 1,683,707 | -558,929 | $7.71M | $2.21M | 1.77% | -$5.51M |